Abstract: Disclosed are a polyethylene glycol conjugate drug, and a preparation method therefor and the use thereof. Specifically, the present invention relates to a polyethylene glycol conjugate drug represented by formula A or a pharmaceutically acceptable salt thereof, a method for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, an intermediate for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, and the use of the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof in the preparation of a drug.

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: A polyethylene glycol conjugate drug synergist, a preparation method therefor, and use thereof, specifically relating to a polyethylene glycol conjugate drug synergist as shown in formula I or a pharmaceutically acceptable salt thereof, a preparation method for the polyethylene glycol conjugate drug synergist or the pharmaceutically acceptable salt thereof, an intermediate for preparing the polyethylent glycol conjugate drug synergist or the pharmaceutically acceptable salt thereof, a composition containing the polyethylene glycol conjugate drug synergist or the pharmaceutically acceptable salt thereof, and use of the polyethylene glycol conjugate drug synergist or the pharmaceutically acceptable salt thereof in preparation of a drug.

Abstract: The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.

Abstract: A lens assembly for display includes a display, a lens assembly, and a prism assembly. The display emits a first light beam. The lens assembly includes a first, second, and third lenses. The prism assembly includes a first, second prisms, and an optical multilayer film, wherein the first prism includes a first, second, and third surfaces and the second prism includes a fourth, fifth, sixth, seventh, and eighth surfaces. The lens assembly for display satisfies at least one of following conditions: 0.60?Din/TTL?0.75; 0.28?Din/f123?0.35; 4.56 mm?Din?5.02 mm; wherein Din is an effective optical diameter of the light incident surface, TTL is an interval from the light incident surface to the light emitting surface along the optical axis, and f123 is an effective focal length of a combination of the first lens, the second lens, and the third lens.

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.

Abstract: A lens assembly for display includes a display, a lens assembly, and a prism assembly. The display emits a first light beam. The prism assembly includes a first, second prisms, and an optical multilayer film, wherein the first prism includes a first, second, and third surfaces; the second prism includes a fourth, fifth, sixth, seventh, and eighth surfaces; and the optical multilayer film is disposed between the third and fifth surfaces. A second light beam enters the first prism through the first surface and exits by the second surface. The first light beam exits the lens assembly and enters the second prism through the eighth surface, and exits the first prism by the second surface. The lens assembly and the prism assembly satisfy: 0.80%?E1/E0?0.95%; wherein E0 is an energy of the first light beam emitted from the display and E1 is an energy of the first light beam passes through the lens assembly.

Abstract: The disclosure relates to the technical field of medicine, specifically to a polyethylene glycol conjugated drug, a preparation method therefor and use thereof, and relates in particular to a polyethylene glycol conjugated drug represented by formula (I) or a pharmaceutically acceptable salt thereof. The disclosure further relates to a method for preparation of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, and use of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof in preparation of a medicament.

Abstract: The disclosure relates to the technical field of medicine and in particular to a polyethylene glycol conjugated drug of formula I or a pharmaceutically acceptable salt thereof. The disclosure further relates to a method for preparation and an intermediate of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, and use of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof in preparation of a medicament.

Abstract: A lens assembly for display includes a display, a lens assembly, and a prism assembly. The display emits a first light beam. The prism assembly includes a first, second prisms, and an optical multilayer film, wherein the first prism includes a first, second, and third surfaces; the second prism includes a fourth, fifth, sixth, seventh, and eighth surfaces; and the optical multilayer film is disposed between the third and fifth surfaces. A second light beam enters the first prism through the first surface and exits by the second surface. The first light beam exits the lens assembly and enters the second prism through the eighth surface, and exits the first prism by the second surface. The lens assembly and the prism assembly satisfy: 0.80%?E1/E0?0.95%; wherein E0 is an energy of the first light beam emitted from the display and E1 is an energy of the first light beam passes through the lens assembly.

Abstract: This invention provides an accurate current mirror circuit in a low voltage headroom applied to common-anode laser drivers, including a reference current detection unit, a tail current source unit, and a control unit. The reference current detection unit generates a bias voltage and a reference voltage according to a reference current from the reference current source; the tail current source unit receives the bias voltage and generate a mirror current accordingly; the control unit receives the reference voltage and an output voltage corresponding to the mirror current and carry out a feedback regulation to the bias voltage accordingly. In this invention, the reference voltage and the output voltage are locked at same level, and then the bias voltage is mirrored to generate the mirror current outputted to the laser, thus avoiding the problem of inaccurate current output caused by the offset of the control unit in the low voltage headroom.

Abstract: This invention provides a multi-bit digitally controlled accurate current source circuit including a reference current detection unit, a voltage buffer unit, a digital logic control unit, a switch array unit, and a current source array unit. The reference current detection unit generates a first bias voltage according to a reference current; the voltage buffer unit receives the first bias voltage, and generate a buffer voltage accordingly; the digital logic control unit receives the buffer voltage, and generate a digital control signal accordingly; the switch array unit receives the digital control signal, and generate on-off signals accordingly; and the current source array unit receives and responds to the on-off signals so as to control turn-on and turn-off of the current sources in the current source array unit. In this invention, by adding only one voltage buffer, a cascode current source if formed, and an area saving accurate current source is realized.

Abstract: This invention provides a multi-bit digitally controlled accurate current source circuit including a reference current detection unit, a voltage buffer unit, a digital logic control unit, a switch array unit, and a current source array unit. The reference current detection unit generates a first bias voltage according to a reference current; the voltage buffer unit receives the first bias voltage, and generate a buffer voltage accordingly; the digital logic control unit receives the buffer voltage, and generate a digital control signal accordingly; the switch array unit receives the digital control signal, and generate on-off signals accordingly; and the current source array unit receives and responds to the on-off signals so as to control turn-on and turn-off of the current sources in the current source array unit. In this invention, by adding only one voltage buffer, a cascode current source if formed, and an area saving accurate current source is realized.

Abstract: This invention provides an accurate current mirror circuit in a low voltage headroom applied to common-anode laser drivers, including a reference current detection unit, a tail current source unit, and a control unit. The reference current detection unit generates a bias voltage and a reference voltage according to a reference current from the reference current source; the tail current source unit receives the bias voltage and generate a mirror current accordingly; the control unit receives the reference voltage and an output voltage corresponding to the mirror current and carry out a feedback regulation to the bias voltage accordingly. In this invention, the reference voltage and the output voltage are locked at same level, and then the bias voltage is mirrored to generate the mirror current outputted to the laser, thus avoiding the problem of inaccurate current output caused by the offset of the control unit in the low voltage headroom.